MVM Life Science Partners
Growth equityLondon · Seed–Late Stage · 11 people tracked
Also known as MVM PARTNERS LLP · MVM PARTNERS, LLC
Investment thesis
MVM invests broadly across healthcare and life sciences, including medical technology, pharmaceuticals, diagnostics, digital health, health IT, life science tools, and contract research and manufacturing. It provides equity to companies with high growth potential that address significant unmet needs in large addressable markets, prioritizing differentiated technologies with durable competitive protection through IP, market-entry barriers, statutory exclusivity, or unique branding. MVM partners closely with best-in-class management teams to accelerate growth, drive strategic acquisitions, and establish new standards of care. It maintains a concentrated portfolio and typically deploys $20-100 million per company over the holding period.
Source: firm website, verified Aug 3, 2026.
Team · 11 people
from public directories
What they invest in
from 7 of 8 portfolio companiesHealthtech ×5Biotech ×2
HQs:United States×8
Investments · 8 tracked
founders shown can be your intro pathHealthtechCold Spring Harbor, US
James Lackie(Director)Eric Bednarski(Director)Frank Flaut III(Director)Ron Goldman(Executive Officer, Director)Christopher Gabrieli(Director)
Board seatStephen ReedersAkhilesh Pathipati· per SEC Form D · $18.3M raise · filed Apr 2022
HealthtechBellevue, US
Jeffrey Poole(Executive Officer)Mark Foster(Executive Officer, Director)Steven Dimmer(Executive Officer, Director, Promoter)Eric Bell(Director)Dong-Gun Kim(Director)
Board seatJack TanakaEric Fritz· per SEC Form D · $45.3M raise · filed Mar 2025
BiotechNewport Beach, US
Davis Corley(Executive Officer)
Board seatEric BednarskiAkhilesh Pathipati· per SEC Form D · $67.6M raise · filed Sep 2022
HealthtechYardley, US
Per Djupesland(Executive Officer, Director)Michele Janis(Executive Officer)Larry Pickering(Director)Patrick O'Neill(Director)Peter Miller(Executive Officer, Director)Klaas De Boer(Director)
Board seatEric BednarskiKyle Dempsey· per SEC Form D · $4.7M raise · filed May 2024
BiotechPhiladelphia, US
David Brand(Executive Officer, Director)Richard Kollender(Director)Martin Edwards(Director)Eric Bednarski(Director)Gregory Lumpkin(Executive Officer)Derek Ferguson(Director)
Board seatEric Bednarski· per SEC Form D · $2M raise · filed Feb 2016
HealthtechCampbell, US
Richard Feachem(Director)Steve Zadig(Executive Officer, Director)Tom Saunders(Director)Nersi Nazari(Executive Officer, Director)
Board seatStephen Reeders· per SEC Form D · $38.1M raise · filed Oct 2017
Campbell, US
John Tighe(Executive Officer, Director)Patrick Berbon(Director)Stephen Reeders(Director)Amir Belson(Director)Balaji Muralidhar(Director)
Board seatStephen Reeders· per SEC Form D · $26.9M raise · filed Jan 2016
GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors
HealthtechTempe, US
Per Langoe(Executive Officer, Director)David G. Brachman(Executive Officer, Director)Geoff Pardo(Director)Prattipati Laxminarain(Director)Kyle Dempsey(Director)Camilo Rico(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does MVM Life Science Partners invest at?
- MVM Life Science Partners invests at the Seed, Series A, Growth, Late Stage stages.
- What is MVM Life Science Partners's typical check size?
- MVM Life Science Partners typically writes checks of $20M – $100M.
- What sectors does MVM Life Science Partners focus on?
- MVM Life Science Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is MVM Life Science Partners located?
- MVM Life Science Partners is headquartered in London, GB.
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.